AcelRx receives European Commission approval for DZUVEO(TM)

AcelRx's DZUVEO receives EU approval for management of acute moderate to severe pain in medically monitored settings REDWOOD CITY, Calif., June 27, 2018 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx o... Biopharmaceuticals, Drug Delivery, Regulatory AcelRx Pharmaceuticals, DZUVEO, DSUVIA , sufentanil, sublingual
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news